HIV
2,086
203
294
1,352
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
394 trials with published results (19%)
Research Maturity
1352 completed trials (65% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.5%
73 terminated out of 2086 trials
94.9%
+8.4% vs benchmark
14%
285 trials in Phase 3/4
29%
394 of 1352 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1352 completed trials
Clinical Trials (2086)
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Immunogenicity of MF59-adjuvanted Versus High-dose Influenza Vaccine in People With HIV: a Randomized Clinical Trial
Analytic Treatment Interruption (ATI) to Assess HIV Cure
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia
Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer
Olfactory Function and Model-Based Behavior in People Living With HIV and SUD
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
SHARE Program: SUSTAIN
Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption
Small Trial of Alendronate Impact on the Reservoir of HIV
Resistance Profile to Antiretroviral Medications in Individuals Living With HIV Who Failed a First-Line Regimen With Tenofovir / Lamivudina and Dolutegravir in Brasil
Healthy Choices to Reduce Stigma and Improve Self-Management of Alcohol and HIV Among Young Adults
HIV-Mental Illness Stigma Reduction and Outcomes in Malawi
A Trial to Evaluate an HIV Envelope Trimer, N332-GT5 gp140, Adjuvanted With SMNP in Adult Participants Without HIV
Evaluating Smoking Cessation Interventions for PWH in South Africa
Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV
Kulindana: Community-friendly Delivery and Monitoring of TPT to Improve Uptake and Reduce TB Transmission
Comparative Trial Between Ainuovirine(ANV)/Lamivudine(3TC)/Tenofovir(TDF) and Efavirenz(EFV)/Lamivudine/Tenofovir Regimens
Skeletal Muscle Energetics and Fatiguability in Older Individuals